Overview: Zynerba Pharmaceuticals is a company developing cannabinoid therapies for rare and near-rare neuropsychiatric conditions. The company’s leading drug candidate is a pharmaceutical-grade transdermal CBD gel. Its transdermal CBD gel, called Zygel, is undergoing late-stage clinical trials testing its safety...

You must subscribe to NICI Membership Lifetime to view this content. To learn more and access special member pricing contact our VIP team at 1-866-298-7257. 

Sign In

Enter your details below.